Venturing into chemical frontiers: delving into the realm of potential outcomes

In an exciting development for the chemistry community, Graeme Robb, the Associate Principal Scientist at AstraZeneca, will be the speaker for an upcoming webinar. This event promises to be a fascinating exploration of Design of Experiments, data visualization, modelling, and machine learning, all key areas in modern chemistry.

Graeme Robb, a Chartered Chemist and alumnus of the University of Edinburgh with a Ph.D. and Masters degree in chemistry, has spent the last 15 years working as a computational chemist at AstraZeneca. His current role involves simulating 3D molecular structures of drugs and their target proteins, a crucial aspect of cancer drug discovery.

The webinar is not just significant for AstraZeneca, but for the entire chemistry industry. Historically, researchers from pharmaceutical companies and academic institutions have developed software using machine learning and computational chemistry methods to help chemists predict the properties of future molecules in drug development and other applications.

JMP, a part of SAS since 1989, will be playing a key role in this webinar. JMP software is widely used by chemists to harness these methods for efficient product development. SAS, the largest independent vendor in the business intelligence market and the leader in business analytics software and services, helps customers make better decisions faster through innovative solutions.

Phil Kay, a Statistical Consultant for JMP, will also be participating in the webinar. Prior to joining the Royal Society of Chemistry, Kay was the producer of the award-winning Naked Scientists. Ben Valsler, the digital editor of our website magazine, producing video and podcasts, will also be present.

The potential for organic molecules is vast, with estimates suggesting more than 10^10 possibilities. Graeme Robb has established numerical and statistical learning methods for modelling and predicting the properties of these molecules, a skill that is essential for the efficient exploration of possibilities in chemistry.

Chemists, like Graeme Robb, use computational and data-driven methods to explore possibilities efficiently. This webinar promises to be a valuable resource for anyone interested in the future of chemistry and the role of technology in drug development.

SAS has been serving customers worldwide since 1976, demonstrating a long-standing commitment to innovation and excellence in the field of data analysis. This webinar is a testament to that commitment and a promising glimpse into the future of chemistry.